Skip to content

Head Positioning After Retina Detachment Repair

Head Positioning Duration After Retinal Detachment Repair With Vitrectomy and Gas

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03714503
Enrollment
20
Registered
2018-10-22
Start date
2019-04-08
Completion date
2028-12-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retina; Detachment, Rhegmatogenous

Brief summary

This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tamponade. The investigator will conduct a single arm phase II study using a Simon's two-stage design

Detailed description

A. Study Objectives: To determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after PPV using C3F8 gas as a tamponade. * Primary outcome: retina anatomical success at 3 months post-operatively * Secondary outcome: retina anatomical success at 1 year post-operatively B. Study Type and Design: Single arm phase II study to assess its effectiveness and warrant interest in further development. A Simon's two-stage design will be used to test the following hypotheses: null hypothesis (HO): P\<=0.6 versus alternative hypothesis (HI): p \>= 0.85. C. Sample size, statistical methods, and power calculation 1\. The sample size calculations are based on a Simon's two-stage minimax design. The Investigators plan to recruit 20 patients (20 eyes) with one day post-operative head positioning. This trial will run as a single-arm study in two stages. In the first stage, the Investigators will define a futility rate of 60%. Thus, 11 patients will be enrolled in this stage and if seven or less than seven patients are not declared a "success", the Investigators will terminate this trial after the first stage. If eight or more successes are found in the first stage, the Investigators will continue to the second stage where the Investigators will enroll an additional 9 patients taking the total sample size to 20 patients. The treatment will be considered as promising for future research if the results find that 16 or more than 16 of the 20 patients are declared a 'success' (based on the literature review and a retrospective study, a success rate of 85% is chosen). This minimax design has an expected sample size of 14 patients and a probability of early termination (PET) of 70%. An analogous calculation for the Optimal Simon's design gives a total sample size of 28 but with the same expected sample size of 14, and so the Investigators have decided to adopt the minimax design.

Interventions

DEVICERetina re-attachment repair using C3F8 gas tamponade

Assigning a one day post-operative head positioning

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Simon's two stage

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability to understand and the willingness to sign a written informed consent * Subjects must be diagnosed with primary rhegmatogenous retinal detachment with inferior breaks * Subjects must be 18 years and older. * Women of child-bearing potential must agree to take rapid urine pregnancy test before surgical procedure and have negative result.

Exclusion criteria

* pediatric population * pregnant women * a previous retinal detachment repair in the study eye * history of scleral buckling in the study eye * trauma as a cause of the retinal detachment * asymptomatic longstanding retinal detachments * non-compliance with post-operative treatment * phakic retinal detachment * exudative retinal detachment * retinoschisis related retinal detachment

Design outcomes

Primary

MeasureTime frameDescription
Retina attachment on clinical exam using the indirect ophthalmoscope3 monthsRetina remained attached on indirect ophthalmoscopy exam with scleral depression 360 degrees

Secondary

MeasureTime frameDescription
Retina attachment on clinical exam using the indirect ophthalmoscope1 yearRetina remained attached on indirect ophthalmoscopy exam with scleral depression 360 degrees

Countries

United States

Contacts

CONTACTAriana Madrigal
amadrigal2@kumc.edu9135880105
CONTACTAbby Strickland
astrickland2@kumc.edu913-588-6600
PRINCIPAL_INVESTIGATORRadwan Ajlan, MD

University of Kansas Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026